Poland: EIB lends up to EUR 10 million to Scope Fluidics to develop diagnostics equipment for infectious diseases

Sep 07, 2020

The EIB has agreed to lend up to EUR 10 million to Scope Fluidics, a Polish medical technology company developing innovative products in the field of medical diagnostics. Scope Fluidics uses microfluidic technologies (involving the manipulation of small quantities of test samples within a disposable diagnostic cartridge) and focuses on rapid characterization of antibiotic resistance of bacteria and on ultra-fast detection of bacterial and viral pathogens (including COVID-19).


Other news

Cookies help us deliver our services. By using our services, you agree to our use of cookies.